Apoptosis and anergy of T cell induced by pancreatic stellate cells-derived galectin-1 in pancreatic cancer

Tumor Biology

Volumn 36, Issue 7, 2015, Pages 5617-5626

  Tang, Dong ^a   Gao, Jun ^a   Wang, Sen ^b   Yuan, Zhongxu ^c   Ye, Nianyuan ^a   Chong, Yang ^a   Xu, Chuanqi ^a   Jiang, Xuetong ^a   Li, Bin ^a   Yin, Wei ^a   Miao, Yi ^b   Wang, Daorong ^a   Jiang, Kuirong ^b  

^a NORTHERN JIANGSU PEOPLE S HOSPITAL   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c Anhui No 2 Provincial People's Hospital   (China)

Author keywords

Galectin 1; Microenvironment; Pancreatic cancer; Pancreatic stellate cells; T cells

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CASPASE; CASPASE 3; CASPASE 8; CASPASE 9; GALECTIN 1; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; LYMPHOTOXIN; VIMENTIN; CYTOKINE;

ADULT; ANALYSIS OF VARIANCE; APOPTOSIS; ARTICLE; CELL ISOLATION; CLONAL ANERGY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PANCREATIC STELLATE CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; TUMOR IMMUNITY; WESTERN BLOTTING; AGED; BIOSYNTHESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; MIDDLE AGED; PANCREAS TUMOR; PATHOLOGY; TUMOR MICROENVIRONMENT;

ADULT; AGED; APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CLONAL ANERGY; CYTOKINES; FEMALE; GALECTIN 1; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PANCREATIC STELLATE CELLS; T-LYMPHOCYTES; TUMOR MICROENVIRONMENT;

EID: 84938198827     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-015-3233-5     Document Type: Article

References (49)

1. Campbell PJ, Yachida S, Mudie LJ, Stephens PJ, Pleasance ED, et al. The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature. 2010;467:1109–13.
2. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277–300.
3. Jones S, Hruban RH, Kamiyama M, Borges M, Zhang X, et al. Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene. Science. 2009;324:217.
4. Kleeff J, Beckhove P, Esposito I, Herzig S, Huber PE, et al. Pancreatic cancer microenvironment. Int J Cancer. 2007;121:699–705.
5. Neesse A, Michl P, Frese KK, Feig C, Cook N, et al. Stromal biology and therapy in pancreatic cancer. Gut. 2011;60:861–8.
6. Olive KP, Jacobetz MA, Davidson CJ, Gopinathan A, McIntyre D, et al. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science. 2009;324:1457–61.
7. Kraman M, Bambrough PJ, Arnold JN, Roberts EW, Magiera L, et al. Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha. Science. 2010;330:827–30.
8. Ganss R, Hanahan D. Tumor microenvironment can restrict the effectiveness of activated antitumor lymphocytes. Cancer Res. 1998;58:4673–81.
9. Guturu P, Shah V, Urrutia R. Interplay of tumor microenvironment cell types with parenchymal cells in pancreatic cancer development and therapeutic implications. J Gastrointest Cancer. 2009;40:1–9.
10. Salatino M, Croci DO, Bianco GA, Ilarregui JM, Toscano MA, et al. Galectin-1 as a potential therapeutic target in autoimmune disorders and cancer. Expert Opin Biol Ther. 2008;8:45–57.
11. Hughes RC. Galectins as modulators of cell adhesion. Biochimie. 2001;83:667–76.
12. Rabinovich GA. Galectin-1 as a potential cancer target. Br J Cancer. 2005;92:1188–92.
13. Cimmino F, Schulte JH, Zollo M, Koster J, Versteeg R, et al. Galectin-1 is a major effector of TrkB-mediated neuroblastoma aggressiveness. Oncogene. 2009;28:2015–23.
14. Juszczynski P, Ouyang J, Monti S, Rodig SJ, Takeyama K, et al. The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma. Proc Natl Acad Sci U S A. 2007;104:13134–9.
15. Tang D, Zhang J, Yuan Z, Gao J, Wang S, et al. Pancreatic satellite cells derived galectin-1 increase the progression and less survival of pancreatic ductal adenocarcinoma. PLoS ONE. 2014;9(3):e90476.
16. He J, Baum LG. Presentation of galectin-1 by extracellular matrix triggers T cell death. J Biol Chem. 2004;279:4705–12.
17. Kovacs-Solyom F, Blasko A, Fajka-Boja R, Katona RL, Vegh L, et al. Mechanism of tumor cell-induced T-cell apoptosis mediated by galectin-1. Immunol Lett. 2010;127:108–18.
18. Motran CC, Molinder KM, Liu SD, Poirier F, Miceli MC. Galectin-1 functions as a Th2 cytokine that selectively induces Th1 apoptosis and promotes Th2 function. Eur J Immunol. 2008;38:3015–27.
19. Rubinstein N, Alvarez M, Zwirner NW, Toscano MA, Ilarregui JM, et al. Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; a potential mechanism of tumor-immune privilege. Cancer Cell. 2004;5:241–51.
20. Vonlaufen A, Joshi S, Qu C, Phillips PA, Xu Z, et al. Pancreatic stellate cells: partners in crime with pancreatic cancer cells. Cancer Res. 2008;68:2085–93.
21. Xu Z, Vonlaufen A, Phillips PA, Fiala-Beer E, Zhang X, et al. Role of pancreatic stellate cells in pancreatic cancer metastasis. Am J Pathol. 2010;177:2585–96.
22. Masamune A, Satoh M, Hirabayashi J, Kasai K, Satoh K, et al. Galectin-1 induces chemokine production and proliferation in pancreatic stellate cells. Am J Physiol Gastrointest Liver Physiol. 2006;290:G729–736.
23. Chu GC, Kimmelman AC, Hezel AF, DePinho RA. Stromal biology of pancreatic cancer. J Cell Biochem. 2007;101:887–907.
24. Ikenaga N, Ohuchida K, Mizumoto K, Cui L, Kayashima T, et al. (2010) CD10+ pancreatic stellate cells enhance the progression of pancreatic cancer. Gastroenterology 139: 1041-1051, 1051 e1041-1048.
25. Tang D, Yuan Z, Xue X, Lu Z, Zhang Y, et al. High expression of Galectin-1 in pancreatic stellate cells plays a role in the development and maintenance of an immunosuppressive microenvironment in pancreatic cancer. Int J Cancer. 2012;130:2337–48.
26. Bachem MG, Schneider E, Gross H, Weidenbach H, Schmid RM, et al. Identification, culture, and characterization of pancreatic stellate cells in rats and humans. Gastroenterology. 1998;115:421–32.
27. Ohuchida K, Mizumoto K, Murakami M, Qian LW, Sato N, et al. Radiation to stromal fibroblasts increases invasiveness of pancreatic cancer cells through tumor-stromal interactions. Cancer Res. 2004;64:3215–22.
28. Hwang RF, Moore T, Arumugam T, Ramachandran V, Amos KD, et al. Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res. 2008;68:918–26.
29. Masamune A, Kikuta K, Watanabe T, Satoh K, Satoh A, et al. Pancreatic stellate cells express Toll-like receptors. J Gastroenterol. 2008;43:352–62.
30. Park HD, Lee Y, Oh YK, Jung JG, Park YW, et al. Pancreatic adenocarcinoma upregulated factor promotes metastasis by regulating TLR/CXCR4 activation. Oncogene. 2011;30:201–11.
31. Marigo I, Bosio E, Solito S, Mesa C, Fernandez A, et al. Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor. Immunity. 2010;32:790–802.
32. Epardaud M, Elpek KG, Rubinstein MP, Yonekura AR, Bellemare-Pelletier A, et al. Interleukin-15/interleukin-15R alpha complexes promote destruction of established tumors by reviving tumor-resident CD8+ T cells. Cancer Res. 2008;68:2972–83.
33. Plate JM, Harris JE. Immunobiotherapy directed against mutated and aberrantly expressed gene products in pancreas cancer. J Cell Biochem. 2005;94:1069–77.
34. Perillo NL, Pace KE, Seilhamer JJ, Baum LG. Apoptosis of T cells mediated by galectin-1. Nature. 1995;378:736–9.
35. Fitzner B, Walzel H, Sparmann G, Emmrich J, Liebe S, et al. Galectin-1 is an inductor of pancreatic stellate cell activation. Cell Signal. 2005;17:1240–7.
36. Lin WW, Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest. 2007;117:1175–83.
37. Smyth MJ, Dunn GP, Schreiber RD. Cancer immunosurveillance and immunoediting: the roles of immunity in suppressing tumor development and shaping tumor immunogenicity. Adv Immunol. 2006;90:1–50.
38. Yang RY, Liu FT. Galectins in cell growth and apoptosis. Cell Mol Life Sci. 2003;60:267–76.
39. Liu FT. Regulatory roles of galectins in the immune response. Int Arch Allergy Immunol. 2005;136:385–400.
40. Tang D, Wang D, Yuan Z, Xue X, Zhang Y, et al. Persistent activation of pancreatic stellate cells creates a microenvironment favorable for the malignant behavior of pancreatic ductal adenocarcinoma. Int J Cancer. 2013;132:993–1003.
41. Blaser C, Kaufmann M, Muller C, Zimmermann C, Wells V, et al. Beta-galactoside-binding protein secreted by activated T cells inhibits antigen-induced proliferation of T cells. Eur J Immunol. 1998;28:2311–9.
42. Toscano MA, Bianco GA, Ilarregui JM, Croci DO, Correale J, et al. Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death. Nat Immunol. 2007;8:825–34.
43. Hahn HP, Pang M, He J, Hernandez JD, Yang RY, et al. Galectin-1 induces nuclear translocation of endonuclease G in caspase- and cytochrome c-independent T cell death. Cell Death Differ. 2004;11:1277–86.
44. Ion G, Fajka-Boja R, Kovacs F, Szebeni G, Gombos I, et al. Acid sphingomyelinase mediated release of ceramide is essential to trigger the mitochondrial pathway of apoptosis by galectin-1. Cell Signal. 2006;18:1887–96.
45. Duner S, Lopatko Lindman J, Ansari D, Gundewar C, Andersson R. Pancreatic cancer: the role of pancreatic stellate cells in tumor progression. Pancreatology. 2011;10:673–81.
46. Kikuta K, Masamune A, Watanabe T, Ariga H, Itoh H, et al. Pancreatic stellate cells promote epithelial-mesenchymal transition in pancreatic cancer cells. Biochem Biophys Res Commun. 2010;403:380–4.
47. Berberat PO, Friess H, Wang L, Zhu Z, Bley T, et al. Comparative analysis of galectins in primary tumors and tumor metastasis in human pancreatic cancer. J Histochem Cytochem. 2001;49:539–49.
48. Li L, Bimmler D, Graf R, Zhou S, Sun Z, et al. PSP/reg inhibits cultured pancreatic stellate cell and regulates MMP/TIMP ratio. Eur J Clin Invest. 2011;41:151–8.
49. Montiel JL, Monsivais-Urenda A, Figueroa-Vega N, Moctezuma JF, Burgos-Vargas R, et al. Anti-CD43 and anti-galectin-1 autoantibodies in patients with systemic lupus erythematosus. Scand J Rheumatol. 2010;39:50–7.